Last reviewed · How we verify

NCT05147506

Digital Therapeutic for Depression After Head Injury in Current and Former US Military Personnel

Active, enrolled NA Last updated 13 June 2024
What this trial tests

NA trial testing CNRM DTx in Depressive Symptoms in 113 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
22 June 2022
Primary endpoint
30 October 2024
1 January 2025

Quick facts

Lead sponsorHenry M. Jackson Foundation for the Advancement of Military Medicine
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment113
Start date22 June 2022
Primary completion30 October 2024
Estimated completion1 January 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Henry M. Jackson Foundation for the Advancement of Military Medicine

Who can join

Adults 18 to 65, any sex, with Depressive Symptoms or Mild Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Center for Neuroscience and Regenerative Medicine (CNRM) Clinical Trials Unit has developed the first cognitive-behavioral therapy (CBT) digital therapeutic (DTx) mobile application to counteract depressive symptoms in military service members and veterans with a history of mild traumatic brain injury (mTBI). This trial will assess the efficacy of the novel CBT-DTx for depression following mTBI compared to an educational comparison DTx.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Depressive Symptoms

Currently open trials in the same condition.

Other Henry M. Jackson Foundation for the Advancement of Military Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05147506.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing